Elanco announced that the U.S. Department of Agriculture has issued a veterinary biologics license for its Titanium 5 + PH-M, a new vaccine that protects cattle against the viruses and bacteria most associated with bovine respiratory disease (BRD).
Marketed by Elanco, Titanium 5 + PH-M provides modified-live virus (MLV) protection against bovine viral diarrhea (BVD) types 1 and 2, bovine respiratory syncytial virus (BRSV), infectious bovine rhinotracheitis (IBR) and parainfluenza3 (PI3). Each dose also protects against Mannheimia haemolytica and Pasteurella multocida bacteria, and is safe for cattle at all stages of production, Elanco said.
"This means veterinarians and producers can protect cattle against the important BRD-causing viruses and bacteria with just one vaccine," Dr. Brett Terhaar, Elanco beef technical services, said. "Titanium 5 + PH-M is well-suited for branding and weaning/preconditioning vaccination protocols in cow/calf operations, as well as arrival programs in stocker operations and feedyards. Producers should partner with their veterinarians to determine the best way to incorporate this new vaccine into herd-health protocols designed to fight BRD."
Titanium 5 + PH-M is a combination of two vaccines. Its viral component, Titanium 5, delivers modified-live protection against five important viruses that cause BRD. Its PH-M component provides coverage against two bacteria that are well-known for causing pasteurellosis (part of the BRD complex).
The new vaccine is formulated with a low-reactive, water-soluble adjuvant. The result is a low-volume (2 mL), subcutaneous dose that is consistent with Beef Quality Assurance guidelines.
Titanium 5 + PH-M is available in 10-dose and 50-dose packages through veterinarians and animal health distributors.